Tuberculosis (TB) has attracted attention as a leading global public problem resulting in the commitment of substantial resources to research and control activities. Although significant scientific advances have ensued, key translational tools are lacking. Chief among these are biomarkers to assist in developing new approaches and modalities for the prevention and management of TB. Their development has been retarded, in part, is because of limited understanding of the host-bacterial relationship. The current proposal broadens the focus of the U.S.-Brazil collaboration to address more fundamental issues concerning host susceptibility to Mycobacterium tuberculosis (Mtb) infection, the immunodynamics of recent TB infection, and bacterial factors that may play a role in treatment relapse. The high impact translational goal of this program, then, is to discover biomarkers of clinical importance to the prevention and treatment of TB.
The Specific Aims are 1 .To determine the immunologic basis for resistance and susceptibility to Mtb infection and the correlate biomarkers. The results may provide new concepts as well as biomarkers relevant to the development of novel treatments, TB vaccines and adjuvants that target innate immunity. 2. to elucidate the immunodynamics of evolving Mtb infection and to discover measurable biomarkers in clinical samples that could accurately identify recent Mtb infection and/or active Mtb replication, thereby identifying persons at high risk of TB. 3. to determine whether Mtb isolates associated with relapse 1) have sub clinical resistance below or around clinical breakpoints for the antibiotic, 2) are more tolerant of antibiotics as measured by BACTEC assays or 3) display a """"""""loss-of-synergy"""""""" phenotype. Further, to determine whether genetic mechanisms associated with these phenotypes include 1) embB mutations, 2) pump mutations such as iniA 3) and to discover other as yet unknown mechanisms. These studies will characterize phenotypic and genotypic biomarkers of Mtb that are associated with treatment failure. TB patients infected with such isolates may require alternative approaches to treatment.

Public Health Relevance

TB is a major global public health concern. The available approaches to prevention and control of TB have failed. This research will provide biomarkers that will be essential to develop improved tools and approaches to control TB.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI065663-07
Application #
8144297
Study Section
Special Emphasis Panel (ZAI1-GSM-M (J1))
Program Officer
Parker, Tina M
Project Start
2005-09-01
Project End
2015-12-31
Budget Start
2011-09-01
Budget End
2012-12-31
Support Year
7
Fiscal Year
2011
Total Cost
$596,258
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Fernandes, P; Ma, Y; Gaeddert, M et al. (2018) Sex and age differences in Mycobacterium tuberculosis infection in Brazil. Epidemiol Infect 146:1503-1510
Acuña-Villaorduña, Carlos; Jones-López, Edward C; Fregona, Geisa et al. (2018) Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease. Eur Respir J 51:
Colangeli, Roberto; Jedrey, Hannah; Kim, Soyeon et al. (2018) Bacterial Factors That Predict Relapse after Tuberculosis Therapy. N Engl J Med 379:823-833
Vinhas, Solange Alves; Jones-López, Edward C; Ribeiro Rodrigues, Rodrigo et al. (2017) Strains of Mycobacterium tuberculosis transmitting infection in Brazilian households and those associated with community transmission of tuberculosis. Tuberculosis (Edinb) 104:79-86
Jones-López, Edward C; Acuña-Villaorduña, Carlos; Fregona, Geisa et al. (2017) Incident Mycobacterium tuberculosis infection in household contacts of infectious tuberculosis patients in Brazil. BMC Infect Dis 17:576
McIntosh, Avery I; Doros, Gheorghe; Jones-López, Edward C et al. (2017) Extensions to Bayesian generalized linear mixed effects models for household tuberculosis transmission. Stat Med 36:2522-2532
Collins, Lauren F; Geadas, Carolina; Ellner, Jerrold J (2016) Diagnosis of Latent Tuberculosis Infection: Too Soon to Pull the Plug on the Tuberculin Skin Test. Ann Intern Med 164:122-4
Salgame, Padmini; Geadas, Carolina; Collins, Lauren et al. (2015) Latent tuberculosis infection--Revisiting and revising concepts. Tuberculosis (Edinb) 95:373-84
Bhatt, Kamlesh; Verma, Sheetal; Ellner, Jerrold J et al. (2015) Quest for correlates of protection against tuberculosis. Clin Vaccine Immunol 22:258-66
Colangeli, Roberto; Arcus, Vic L; Cursons, Ray T et al. (2014) Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans. PLoS One 9:e91024

Showing the most recent 10 out of 19 publications